At the same time, patients with COVID-19 who suffer from diabetes comorbidity are 14.2% more likely to require intensive care [34], implying a correlation with the high expression of angiotensin-converting enzyme 2 (ACE2) in diabetes patients. This evidence concerns the gene ACE2 and COVID-19.